Epithelial skin cancers after kidney transplantation: A retrospective single-centre study of 376 recipients

European Journal of Dermatology

Volumn 26, Issue 3, 2016, Pages 265-270

  Kaufmann, Robin Adrian ^a   Oberholzer, Patrick Antony ^a   Cazzaniga, Simone ^a,b   Hunger, Robert Emil ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Centro Studi GISED   (Italy)

Author keywords

Immunosuppression; Kidney transplant recipients; Nonmelanoma skin cancer

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; EVEROLIMUS; PREDNISONE; RAPAMYCIN; TACROLIMUS; CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PROTEIN KINASE INHIBITOR;

ADULT; ARTICLE; BASAL CELL CARCINOMA; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PUNCH BIOPSY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STANDARDIZED INCIDENCE RATIO; AGE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; INCIDENCE; KERATOSIS, ACTINIC; LONGITUDINAL STUDY; PROCEDURES; RISK FACTOR; SEX DIFFERENCE; SKIN NEOPLASMS; SKIN PIGMENTATION;

ADULT; AGE FACTORS; CALCINEURIN INHIBITORS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KERATOSIS, ACTINIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROTEIN KINASE INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS; SKIN PIGMENTATION;

EID: 85006162858     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2016.2758     Document Type: Article

References (21)

1. Hofbauer GF, Bouwes Bavinck JN, Euvrard S. Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol 2010; 19: 473-82.
2. Jenni D, Hofbauer GF. Keratinocyte cancer and its precursors in organ transplant patients. Curr Probl Dermatol 2015; 46: 49-57.
3. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49: 506-9.
4. Russo I, Piaserico S, Belloni-Fortina A, Alaibac M. Cutaneous melanoma in solid organ transplant patients. G Ital Dermatol Venereol 2014; 149: 389-94.
5. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 253-61.
6. Muehleisen B, Pazhenkottil A, French LE, Hofbauer GF. Nonmelanoma skin cancer in organ transplant recipients: increase without delay after transplant and subsequent acceleration. JAMA Dermatol 2013; 149: 618-20.
7. Bouwes Bavinck JN, Euvrard S, Naldi L, et al. Keratotic skin lesions and other risk factors are associated with skin cancer in organ transplant recipients: a case-control-study in the Netherlands, United Kingdom, Germany, France and Italy. J Invest Dermatol 2007; 127: 1647-56.
8. Yu SH, Bordeaux JS, Baron ED. The immune system and skin cancer. Adv Exp Med Biol 2014; 810: 182-91.
9. Jung JW, Overgaard NH, Burke MT, et al. Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients? Int J Cancer 2016; 138: 281-92.
10. Keller B, Braathen LR, Marti HP, Hunger RE. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med Wkly 2010; 140: w13036.
11. Naghibi O, Naghibi M, Nazemian F. Gender disparity in kidney transplantation. Saudi J Kidney Dis Transpl 2008; 19: 545-50.
12. Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17.
13. Krynitz B, Edgren G, Lindelöf B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study. Int J Cancer 2013; 132: 1429-38.
14. Park GH, Chang SE, Won CH, et al. Incidence of primary skin cancer after organ transplantation: an 18-year single-center experience in Korea. J Am Acad Dermatol 2014; 70: 465-72.
15. Zhang J, Ma L, Xie Z, et al. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients: a single-center experience and literature review. Med Oncol 2014; 31: 32.
16. Traynor C, Jenkinson A, Williams Y, et al. Twenty-year survivors of kidney transplantation. Am J Transplant 2012; 12: 3289-95.
17. Rüegg CP, Graf N, Mühleisen B, et al. Squamous cell carcinoma of the skin induces considerable sustained cost of care in organ transplant recipients. J Am Acad Dermatol 2012; 67: 1242-9.
18. Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM. De novo cancer-related death in Australian liver and cardiothoracic transplant recipients. Am J Transplant 2013; 13: 1296-304.
19. Lloyd A, Klintmalm G, Qin H, Menter A. Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations. Clin Transplant 2015; 29: 110-7.
20. Knoll GA, Kokolo MB, Mallick R, et al. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data. BMJ 2014; 349: g6679.
21. Karayannopoulou G, Euvrard S, Kanitakis J. Differential expression of p-mTOR in cutaneous basal and squamous cell carcinomas likely explains their different response to mTOR inhibitors in organ-transplant recipients. Anticancer Res 2013; 33: 3711-4.